Drug Profile
CS 834
Alternative Names: R 95867; TacapenemLatest Information Update: 02 Feb 2017
Price :
$50
*
At a glance
- Originator Sankyo
- Class Antibacterials; Carbapenems
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 01 Feb 2017 Discontinued - Phase-II for Bacterial infections in Japan, Europe, USA (PO)
- 09 Jun 2003 Suspended - Phase-II for Bacterial infections in Europe (PO)
- 09 Jun 2003 Suspended - Phase-II for Bacterial infections in Japan (PO)